Novo Nordisk Dividends
| NVO Stock | USD 47.42 1.03 2.13% |
At this time, Novo Nordisk's Dividends Paid is very stable compared to the past year. As of the 20th of February 2026, Dividend Yield is likely to grow to 0.04, while Dividend Payout Ratio is likely to drop 0.27. Novo Nordisk's past performance could be the main factor of why investors trade Novo Nordisk AS stock today. Investors should clearly understand every aspect of the Novo Nordisk dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Novo Nordisk's dividend schedule and payout information. Novo Nordisk AS dividends can also provide a clue to the current valuation of Novo Nordisk.
Number Of Dividends | Years Issued 45 | Previous Year 2 Times | Current Year 1 Times | Year Average 1.27 | Volatility 0.45 |
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 49.8 B | 52.3 B | |
| Dividend Yield | 0.04 | 0.04 | |
| Dividend Payout Ratio | 0.51 | 0.27 | |
| Dividend Paid And Capex Coverage Ratio | 1.06 | 1.24 |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Novo Nordisk must own a stock before its ex-dividend date to receive its next dividend.
Novo Nordisk Dividends Paid Over Time
Today, most investors in Novo Nordisk Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Novo Nordisk's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Novo Nordisk dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Novo Nordisk Historical Dividend Yield Growth
A solid dividend growth pattern of Novo Nordisk could indicate future dividend growth is likely, which can signal long-term profitability for Novo Nordisk AS. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is Novo Nordisk AS dividend as a percentage of Novo Nordisk stock price. Novo Nordisk AS dividend yield is a measure of Novo Nordisk stock productivity, which can be interpreted as interest rate earned on an Novo Nordisk investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Recent Novo Nordisk Dividends Paid (per share)
Dividends Paid |
| Timeline |
Novo Nordisk Expected Dividend Income Per Share
Dividend payment represents part of Novo Nordisk's profit that is distributed to its stockholders. It is considered income for that tax year rather than a capital gain. In other words, a dividend is a prize given to shareholders for investing in Novo Nordisk. Novo Nordisk's board of directors can pay out dividends at a planned frequency, such as monthly or quarterly.
$0.95 |
One Year
Novo Nordisk AS expected dividend income per share adjusted for ongoing price standard deviation
Novo Nordisk Past Distributions to stockholders
Will Pharmaceuticals sector continue expanding? Could Novo diversify its offerings? Factors like these will boost the valuation of Novo Nordisk. Anticipated expansion of Novo directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Novo Nordisk data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.05) | Dividend Share 11.7 | Earnings Share 3.66 | Revenue Per Share | Quarterly Revenue Growth (0.08) |
Understanding Novo Nordisk AS requires distinguishing between market price and book value, where the latter reflects Novo's accounting equity. The concept of intrinsic value - what Novo Nordisk's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Novo Nordisk's price substantially above or below its fundamental value.
It's important to distinguish between Novo Nordisk's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Novo Nordisk should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Novo Nordisk's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.